Radiographic Progression Without Corresponding Prostate-specific Antigen Progression in Patients with Metastatic Castration-sensitive Prostate Cancer Receiving Apalutamide: Secondary Analysis of the TITAN TrialWataru Fukuokaya, Takahiro Kimura, Shahrokh F Shariat et al.|European Urology Oncology|2024Cited by 25
Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration‐sensitive prostate cancerWataru Fukuokaya, Akihiro Hirakawa, Takahiro Kimura et al.|Cancer|2025Cited by 3
Prognostic Factors of Trimodal Therapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysisKeiichiro Miyajima, Shahrokh F Shariat, Akihiro Matsukawa et al.|European Urology Focus|2025Cited by 3